Therapeutic Efficacy of Catheter-directed Ethanol Sclerotherapy and Its Impact on Ovarian Reserve in Patients with Ovarian Endometrioma at Risk of Decreased Ovarian Reserve: A Preliminary Study

article OA: green CC0 ⤵ 10 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-10

Catheter-directed ethanol sclerotherapy reduced endometrioma size, dysmenorrhea pain, and CA-125 levels without significantly altering ovarian reserve as measured by AMH.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This retrospective teaching-hospital study evaluated 18 patients with ovarian endometrioma ≥3 cm and preprocedural AMH <2 ng/mL to assess the therapeutic efficacy of catheter-directed ethanol sclerotherapy (CDS) and its impact on ovarian reserve. Using an 8.5-F catheter placed transabdominally or transvaginally into the cyst, aspiration was followed by 99% ethanol with 20-minute retention, with outcomes assessed by ultrasound and serum AMH/CA-125 and dysmenorrhea visual analog scale at baseline and 6 months. At 6 months, cyst size and CA-125 levels decreased significantly, dysmenorrhea scores improved in all patients, but AMH did not change significantly (p = .875). The main limitation is its small sample size and retrospective design, restricting the strength of inferences about ovarian reserve effects. This paper is centrally about endometriosis — specifically, catheter-directed ethanol sclerotherapy for ovarian endometrioma and its effect on ovarian reserve in patients at risk of decreased AMH.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 2,895 characters · extracted from oa-html · click to expand
YUHASpace Repository 0 1033 Cited 0 times in Cited 12 times in Therapeutic Efficacy of Catheter-directed Ethanol Sclerotherapy and Its Impact on Ovarian Reserve in Patients with Ovarian Endometrioma at Risk of Decreased Ovarian Reserve: A Preliminary Study - Authors - Jae Kyung Lee ; So Hyun Ahn ; Hye In Kim ; Yong Jae Lee ; Sunghoon Kim ; Kichang Han ; Man-Deuk Kim ; Seok Kyo Seo - Citation - JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, Vol.29(2) : 317-323, 2022-02 - Journal Title - JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY - ISSN - 1553-4650 - Issue Date - 2022-02 - Keywords - Antimüllerian hormone ; Decreased ovarian function ; Endometriosis ; Endometriotic cyst ; Minimally invasive procedure - Abstract - Study objective: To investigate the therapeutic efficacy of catheter-directed ethanol sclerotherapy (CDS) and its effect on ovarian reserve in patients with endometrioma at risk of decreased ovarian reserve. Design: Retrospective study. Setting: Teaching hospital. Patients: We evaluated 18 patients with ovarian endometrioma measuring ≥3 cm and preprocedural serum antimüllerian hormone (AMH) levels of <2 ng/mL. Interventions: An 8.5-F catheter was inserted either transabdominally or transvaginally into the endometrioma. After aspiration, sclerotherapy with 99% ethanol was performed, with a subsequent 20-minute ethanol retention. Measurements and main results: Ultrasonography was performed preprocedurally and 6 months after CDS to evaluate any recurrence or changes in cyst size. Furthermore, serum AMH levels, cancer antigen 125 (CA-125) levels, and the visual analog scale scores for dysmenorrhea were obtained to analyze the ovarian reserve and treatment efficacy, preprocedurally and at 6 months after CDS. The mean cyst size on ultrasonography and serum CA-125 levels decreased 6 months after CDS (p <.001 and p = .001, respectively). All patients reported a decreased visual analog scale score for dysmenorrhea (p <.001). However, the difference in serum AMH levels before and after CDS was statistically insignificant (p = .875). Conclusion: CDS was efficacious in reducing pain and serum CA-125 levels in patients with low AMH levels without adversely affecting their ovarian reserve. - Appears in Collections: - 1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers 1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers - Yonsei Authors - Kim, Man Deuk(김만득) https://orcid.org/0000-0002-3575-5847 Kim, Sung Hoon(김성훈) https://orcid.org/0000-0002-1645-7473 Kim, Hye In(김혜인) https://orcid.org/0000-0001-7961-5988 Seo, Seok Kyo(서석교) https://orcid.org/0000-0003-3404-0484 Ahn, So Hyun(안소현) Lee, Yong Jae(이용재) https://orcid.org/0000-0003-0297-3116 Han, Ki Chang(한기창) https://orcid.org/0000-0002-9701-9757 Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometrioma

MeSH descriptors

Endometriosis Endometriosis Laparoscopy Ovarian Reserve Anti-Mullerian Hormone Catheters Ethanol Ethanol Female Humans Prospective Studies Retrospective Studies Sclerotherapy

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (41)

Cited by (10)

Source provenance

europepmc
last seen: 2026-06-17T06:13:18.893374+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:24:20.309598+00:00
License: CC0 · commercial use OK